FindTrial
Sign In

Study to evaluate the effectiveness of Keezhanelli Chooranam (KNC) in improving blood sugar control in newly diagnosed Type 2 diabetes patients compared to Madhumegam Chooranam.

Validation of the therapeutic efficacy of the Siddha herbal formulation Keezhanelli Chooranam (KNC) for managing newly diagnosed patients with Type 2 Diabetes Mellitus (Madhumegam): A proof of concept Randomized Clinical Trial - KNC Trial

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095934
Enrollment
70
Registered
2025-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

None listed

Sponsors

Dr Soruban
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Screening glycemic levels: FBS 126 250 mg/dL, PPBS 200 300 mg/dL, HbA1c 6.5 8.0%

Exclusion criteria

Exclusion criteria: Type 1 Diabetes Mellitus or Secondary Diabetes Mellitus Cardiovascular and Central Nervous System Disease Diabetes-related complications Pregnant women

Design outcomes

Primary

MeasureTime frame
Change in HbA1c from baseline to 3 months Change in FBS and PPBS from baseline to 3 months Timepoint: Change in HbA1c from baseline to 3 months Change in FBS and PPBS from baseline to 3 months—

Secondary

MeasureTime frame
Monitoring of adverse events and drug complianceTimepoint: 3 months—

Countries

Sri Lanka

Contacts

Public ContactDr T Soruban

Faculty of Siddha Medicine

dr.vivian@ymail.com0094716222529

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026